While all four classes of HDACs have been implicated in various cancers, Class I HDACs (HDAC1, HDAC2, HDAC3, and HDAC8) are generally considered the most directly and frequently associated with tumorigenesis and are often the primary targets in initial cancer therapeutic strategies [19,20]. This evidence concerns the gene HDAC3 and cancer.